Apixaban Discontinuation for Invasive Or major Surgical procedures (ADIOS): A prospective cohort study

1, 2, 1, 2, 3, 1, 2, 1, 2, 4, 5, 6, 7, 3, 8

1Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA

2Department of Surgery, Thomas Jefferson University, Philadelphia, PA, USA

3Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA, USA

4Department of Pharmacy, Thomas Jefferson University, Philadelphia, PA, USA

5Department of Cardiovascular Medicine, Section of Vascular Medicine, Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA

6Department of Anesthesiology, Thomas Jefferson University, Philadelphia, PA, USA

7Department of Pathology, Thomas Jefferson University, Philadelphia, PA, USA

8Departments of Pharmacy, Clinical Pharmacokinetics Research Unit, National Institutes of Health, Bethesda, MD, USA


Corresponding Author:

Geno Merli, Pharmacology and Experimental Therapeutics, Thomas Jefferson University, 111 S. 10th St, 6270 Gibbon Building, Philadelphia, PA 19107, USA. Email:

Dr. Deborah Siegal served as Guest Editor for this manuscript.

留言 (0)

沒有登入
gif